|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q1 FY2026
As of Mar 9, 2026
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q1 FY2025
As of Mar 17, 2025
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q1 FY2024
As of Mar 6, 2024
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||
| Investments at fair value | ||||||||||||||||
| Non-control/non-affiliate investments | ||||||||||||||||
| Affiliate investments | ||||||||||||||||
| Investment Affiliated Issuer Controlled | ||||||||||||||||
| Total investments at fair value | ||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||
| Accrued interest receivable | ||||||||||||||||
| Interest and fees receivable | ||||||||||||||||
| Deferred financing costs | ||||||||||||||||
| Total deferred financing costs | ||||||||||||||||
| Other assets | ||||||||||||||||
| Total assets | ||||||||||||||||
| Liabilities | ||||||||||||||||
| Credit facility | ||||||||||||||||
| Notes | ||||||||||||||||
| Proceeds from 2026 Notes | ||||||||||||||||
| 2027 Notes | ||||||||||||||||
| 2028 Notes | ||||||||||||||||
| 2029 Notes | ||||||||||||||||
| 2031 Notes | ||||||||||||||||
| Unamortized deferred financing costs | ||||||||||||||||
| Deferred financing costs, net | ||||||||||||||||
| Total debt, less DFC, discounts and premiums, net | ||||||||||||||||
| Distributions payable | ||||||||||||||||
| Incentive fees payable | ||||||||||||||||
| Interest payable | ||||||||||||||||
| Foreign currency forward contracts | ||||||||||||||||
| Secured borrowings | ||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||
| Total liabilities | ||||||||||||||||
| Net assets | ||||||||||||||||
| Common stock, par value | ||||||||||||||||
| Additional paid-in capital | ||||||||||||||||
| Accumulated undistributed (overdistributed) earnings | ||||||||||||||||
| Treasury stock | ||||||||||||||||
| Total net assets | ||||||||||||||||
| Shares of common stock outstanding ($0.01 par value, 100,000,000 shares authorized) | ||||||||||||||||
| Net asset value per share | ||||||||||||||||
Loading...
